Analystreport

Aptose Biosciences Inc. (NASDAQ: APTO) had its price target lowered by analysts at Alliance Global Partners from $12.00 to $8.00. They now have a "buy" rating on th

Aptose Biosciences, Inc. - Common Shares  (APTO) 
Last aptose biosciences, inc. - common shares earnings: 3/10 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: aptose.com/investors